Despite its relative rarity in clinical practice, the Ross procedure provides a survival benefit over mechanical aortic valve replacement in young and middle-aged patients, suggests a meta-analysis published in JAMA Cardiology and presented at the European Society of Cardiology (ESC) Congress in Munich.

Middle-aged men and women with psychological conditions such as anxiety and depression are likely at an increased risk for cardiovascular complications, according to research out of Australia.

Oregon’s only heart transplant program has suspended operations for at least two weeks after three cardiologists either left or announced plans to leave Oregon Health & Science University, The Oregonian reported Aug. 27.

The addition of perivascular fat attenuation to routine coronary computed tomography angiography (CTA) improves risk stratification in heart patients, according to research presented at the European Society of Cardiology (ESC)’s annual symposium in Munich, surpassing current prognostic models to re-classify and predict cardiac deaths with more accuracy.

DUBLIN and MUNICH — August 28, 2018 — Medtronic plc (NYSE:MDT) today announced new findings from the CRYO4PERSISTENT AF clinical trial demonstrating improved quality of life, reduced symptoms from abnormal heart rhythms, and low incidence of reinterventions and repeat ablation procedures.

Jonathan Chen, MD, will join Children's Hospital of Philadelphia (CHOP) as Chief of the Division of Cardiothoracic Surgery on September 1, 2018.

Patients with stable chest pain who were evaluated with coronary CT angiography (CTA) were significantly less likely to experience a heart attack or die from coronary heart disease (CHD) within five years compared to individuals who received standard testing, researchers reported in the New England Journal of Medicine.

The British Heart Foundation announced at this year’s ESC (European Society of Cardiology) Congress it’s launching the Big Beat Challenge, a research award that will throw £30 million—nearly $40 million—behind an innovation that could change the future of cardiovascular medicine.

Among 477,516 people in the Kaiser Permanente Southern California health system who were treated for high blood pressure, those who reached systolic blood pressure below 110 mm Hg at any point during a one-year period were twice as likely to faint or fall as patients who remained above that threshold.

Though it’s used routinely to discourage repeat cardiovascular disease (CVD) events, a daily dose of aspirin is unlikely to prevent a first-time heart attack, according to research presented this week in Munich.